China Botanic Pharmaceutical (CBP) Increases Total Members on Board to 5 with Addition of Mr. Zack Zibing Pan
Tweet
Share
E-mail
China Botanic Pharmaceutical Inc. (NYSE: CBP) today announced that the board increased the number of directors on the board of directors to five at its annual board meeting and appointed Mr. Zack Zibing Pan to its Board of Directors, effective October 15, 2011.
Mr. Pan will serve as an independent director and chairman of the Audit Committee, and a member of the Nomination and Compensation Committee. Mr. Pan is currently the Chief Financial Officer of Biostar Pharmaceuticals, Inc., a Maryland company operated in China through its wholly owned subsidiary and controlled affiliate and listed on the NASDAQ
Mr. Pan will serve as an independent director and chairman of the Audit Committee, and a member of the Nomination and Compensation Committee. Mr. Pan is currently the Chief Financial Officer of Biostar Pharmaceuticals, Inc., a Maryland company operated in China through its wholly owned subsidiary and controlled affiliate and listed on the NASDAQ
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Extra Space Storage names Noah Springer as next CEO
- QXO names Ken West as president and COO, effective September 2026
- AN2 Therapeutics names Cameron Trenor as chief medical officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
